Takeda
Takeda shareholders approve $62bn Shire acquisition
December 6, 2018Business Services Ireland, Japan, M&A, MA, Shire, Takeda, acquisition
Japanese firm Takeda have gained shareholders’ approval for the $62 billion acquisition of the Irish headquartered company Shire Plc. The …
European approval for Takeda’s Alunbrig in ALK+ advanced non-small cell lung cancer
November 27, 2018Research and Development, Sales and Marketing Alunbrig, Cancer, Takeda, lung cancer, pharma
Takeda’s Alunbrig (brigatinib) has been granted marketing approval by the European Commission as a monotherapy to treat anaplastic lymphoma kinase-positive …
Takeda’s subcutaneous vedolizumab proves efficacious in Phase III trial for Ulcerative Colitis
October 22, 2018Sales and Marketing Takeda, UC, biologic, phase III, results, ulcerative colitis, vedolizumab
Japanese pharma firm Takeda has announced that the gut-selective biologic vedolizumab when taken as a subcutaneous (SC) injection, proved efficacious …
Takeda’s lung cancer treatment Alunbrig proves successful in Phase III trial
September 26, 2018Research and Development Alunbrig, R&D, Takeda, phase III, research
Japanese pharma firm Takeda have announced that lung cancer treatment Alunbrig has proven successful in reducing the risk of disease …
Shares in Molecular Templates surge after the announcement of Takeda collaboration
September 20, 2018Business Services, Research and Development Molecular Templates, Shares, Takeda, markets, stocks
Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with …
Takeda set to move from Deerfield Illinois, 1000 jobs affected
September 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Shire, Takeda, deerfield, illinois
Japanese multinational Takeda is set to shut down its US headquarters in Deerfield, Illinois following the final stages of its …
Sanofi’s Dr Eckhard Leifke joins Seattle-based biotech Omeros
August 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Eckhard Leifke, Omeros, Sanofi, Seattle, Takeda
The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical …
Enough talk: Action is required to achieve parity in biotech
August 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, Women in pharma, diversity, feature, pharma, women
Liz Lewis, Chief Counsel & Head of Patient Advocacy at Takeda Oncology tackles the crucial and topical issue of diversity …
Takeda’s Alunbrig topples Pfizer’s Xalkori in ALK-positive lung cancer
July 27, 2018Medical Communications, Research and Development Alunbrig, Cancer, NSCLC, Pfizer, Takeda, Xalkori, lung cancer, pharma
Takeda has unveiled new Phase 3 data showing that its tyrosine kinase inhibitor (TKI) Alunbrig (brigatinib) not only met its …
Takeda’s Ninlaro clears Phase 3 endpoint as maintenance therapy in multiple myeloma
July 12, 2018Medical Communications, Research and Development Ninlaro, Takeda, multiple myeloma, pharma
After making headlines with its mammoth deal to acquire Shire earlier this year, Takeda has emerged with new Phase 3 …
Takeda to sell Osaka site to soften Shire deal’s financial impact
July 5, 2018Manufacturing and Production, Sales and Marketing Japan, Osaka, Shire, Takeda, acquisition, pharma
It’s one of the biggest acquisitions the industry has seen at a total value of $63 billion and after weeks …
Takeda’s Entyvio secures Japanese approval in ulcerative colitis
July 2, 2018Sales and Marketing Entyvio, Japan, Takeda, pharma, ulcerative colitis
Takeda Pharmaceutical has announced that its monoclonal antibody, Entyvio (vedolizumab), has been approved for the treatment of patients with moderately …
Takeda shareholders try to buck Shire deal
June 11, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
A small group of Takeda shareholders have started making a lot of noise over its $62 billion deal for Shire, …
Takeda begins to shore up finances with $280m divestment
May 23, 2018Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical
Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …
Top Ten most popular articles on Pharmafile.com this week
May 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, Novartis, Takeda, Trump, brexit, pharma, pharmafile, top ten
The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …
Latest content
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
